tirzepatide breastfeeding safety guidance Mounjaro While Breastfeeding: & Alternatives breastfeeding tirzepatide guidance can you

Alert your provider immediately if you experience severe nausea, persistent vomiting, rapid weight changes, signs of hypoglycemia, or unexplained hyperglycemia while taking both medications

(Semaglutide / Tirzepatide) Reviewed by Missy Zammichieli, DNP, APRN, FNP-BC Last reviewed May 1, 2026 What this screener tells you The FDA-approved class of prescription weight-management medications is indicated for adults with a BMI of 30 or higher, or a BMI of 27 or higher when paired with a weight-related comorbidity

At Slinic, our clinical governance mirrors these high standards, ensuring every patient journey begins with a foundation of safety and professional accountability

Annals of Nutrition and Metabolism, 66 (Suppl